SULFORAPHANE ALLEVIATES POSTRESUSCITATION LUNG PYROPTOSIS POSSIBLY VIA ACTIVATING THE NRF2/HO-1 PATHWAY

被引:5
|
作者
Li, Yulin [1 ,2 ,3 ]
Yang, Minfei [1 ,2 ,3 ]
Xie, Lutao [1 ,4 ]
Zhang, Gongping [1 ,4 ]
Xu, Jiefeng [1 ,2 ,3 ]
Xu, Shanxiang [1 ,2 ,3 ]
机构
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Emergency Med, 88 Jiefang Rd, Hangzhou 310009, Peoples R China
[2] Key Lab Diag & Treatment Severe Trauma & Burn Zhej, Hangzhou, Peoples R China
[3] Zhejiang Prov Clin Res Ctr Emergency & Crit Care, Hangzhou, Peoples R China
[4] Lishui Muncipal Cent Hosp, Dept Emergency Med, Lishui, Peoples R China
来源
SHOCK | 2023年 / 60卷 / 03期
关键词
Sulforaphane; cardiopulmonary resuscitation; lung injury; pyroptosis; Nrf2/HO-1; pathway; HEART-ASSOCIATION GUIDELINES; CARDIAC-ARREST; CARDIOPULMONARY-RESUSCITATION; INJURY; MECHANISM; OUTCOMES; NRF2; CARE;
D O I
10.1097/SHK.0000000000002180
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Introduction: Sulforaphane (SFN), known as the activator of the nuclear factor E2-related factor 2 (Nrf2)/heme oxygenase 1 (HO-1) pathway, has been proven to protect the lung against various pathological stimuli. The present study aimed to investigate the effect of SFN on lung injury induced by systemic ischemia reperfusion after cardiac arrest and resuscitation.Methods: After animal preparation, 24 pigs were randomly divided into sham group (n = 6), cardiopulmonary resuscitation group (CPR, n = 9), or CPR + SFN group (n = 9). The experimental model was then established by 10 min of cardiac arrest followed by 6 min of CPR. Once spontaneous circulation was achieved, a dose of 2 mg/kg of SFN diluted in 20 mL of saline was intravenously infused with a duration of 5 min. During 4 h of observation after resuscitation, extravascular lung water index (ELWI), pulmonary vascular permeability index (PVPI), and oxygenation index were regularly evaluated. At 24 h after resuscitation, lung tissues were harvested to evaluate the score of lung histopathological injury, the activity of superoxide dismutase, the contents of malondialdehyde, IL-1 beta, and IL-18, and the expression levels of NOD-like receptor pyrin domain 3, cleaved caspase 1, gasdermin D (GSDMD), GSDMD N-terminal, Nrf2, and HO-1.Results: During CPR, spontaneous circulation was achieved in six and seven pigs in the CPR and CPR + SFN groups, respectively. After resuscitation, the indicators of lung injury (ELWI, PVPI, and oxygenation index) were all better in the CPR + SFN group than in the CPR group, in which the differences in ELWI and PVPI at 2, and 4 h after resuscitation were significant between the two groups. In addition, SFN significantly reduced lung injury score, improved oxidative imbalance (superoxide dismutase, malondialdehyde), decreased pyroptosis-related proinflammatory cytokines (IL-1 beta, IL-18), downregulated pyroptosis-related proteins (NOD-like receptor pyrin domain 3, cleaved caspase 1, GSDMD, GSDMD N-terminal), and activated the Nrf2/HO-1 pathway when compared with the CPR group.Conclusion: SFN produced effective postresuscitation lung protection through alleviating lung pyroptosis possibly via activating the Nrf2/HO-1 pathway in pigs.
引用
收藏
页码:427 / 433
页数:7
相关论文
共 50 条
  • [41] Bilirubin ameliorates osteoarthritis via activating Nrf2/HO-1 pathway and suppressing NF-κB signalling
    Zhao, Xinyu
    Duan, Baiqun
    Wu, Jianing
    Huang, Lihui
    Dai, Sheng
    Ding, Jie
    Sun, Meng
    Lin, Xinlu
    Jiang, Yiling
    Sun, Tuyue
    Lu, Ruijie
    Huang, Huirong
    Lin, Guangyong
    Chen, Ruijie
    Yao, Qing
    Kou, Longfa
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (07)
  • [43] Hydroxysafflor yellow A improved retinopathy via Nrf2/HO-1 pathway in rats
    Sun, Zhihui
    Wang, Yuanyuan
    Xu, Rui
    Zhang, Shitong
    Yang, Hongtao
    Song, Jingjing
    Chang, Tao
    OPEN LIFE SCIENCES, 2022, 17 (01): : 284 - 292
  • [44] Urolithin A ameliorates diabetic retinopathy via activation of the Nrf2/HO-1 pathway
    Xu, Zepeng
    Li, Songtao
    Li, Kunmeng
    Wang, Xiaoyu
    Li, Xiaojie
    An, Meixia
    Yu, Xiaoyi
    Long, Xinguang
    Zhong, Ruiying
    Liu, Qiuhong
    Wang, Xiaochuan
    Yang, Yan
    Tian, Ni
    ENDOCRINE JOURNAL, 2022, 69 (08) : 971 - 982
  • [45] Deletion of BACH1 alleviates ferroptosis and protects against LPS-triggered acute lung injury by activating Nrf2/HO-1 signaling pathway
    Wang, Rui-xuan
    Gu, Xing
    Zhang, Si-xue
    Zhao, Yan-jun
    Zhang, Hong-jun
    Li, Fei-yan
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2023, 644 : 8 - 14
  • [46] Neuroprotective effect of sulforaphane on hyperglycemia-induced cognitive dysfunction through the Nrf2/HO-1 pathway
    Wang, Gengyin
    Wang, Liping
    Zhang, Xiaohan
    Wei, Zifeng
    Wang, Kunpeng
    Wang, Jinhua
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2024, 17 (12): : 469 - 476
  • [47] FULLEROL alleviates myocardial ischemia-reperfusion injury by reducing inflammation and oxidative stress in cardiomyocytes via activating the Nrf2/HO-1 signaling pathway
    Ding, M.
    Li, M.
    Zhang, E-M
    Yang, H-L
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (18) : 9665 - 9674
  • [48] Carnosine Alleviates Knee Osteoarthritis and Promotes Synoviocyte Protection via Activating the Nrf2/HO-1 Signaling Pathway: An In-Vivo and In-Vitro Study
    Busa, Prabhakar
    Lee, Sing-Ong
    Huang, Niancih
    Kuthati, Yaswanth
    Wong, Chih-Shung
    ANTIOXIDANTS, 2022, 11 (06)
  • [49] Naringenin can Inhibit the Pyroptosis of Osteoblasts by Activating the Nrf2/HO-1 Signaling Pathway and Alleviate the Differentiation Disorder of Osteoblasts Caused by Microgravity
    Cao, Shuyan
    Wang, Yi
    Zhang, Yalong
    Ren, Jingyi
    Fan, Bingjie
    Deng, Ying
    Yin, Wenzhe
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2024, 72 (46) : 25586 - 25600
  • [50] JuA alleviates liver ischemia-reperfusion injury by activating AKT/NRF2/ HO-1 pathways
    Fang, Haoran
    Xu, Min
    Zhang, Jiakai
    Qin, Hong
    Tang, Hongwei
    He, Yuting
    Guo, Wenzhi
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2024, 1870 (08):